His research is supported by the American Heart Association (AHA) and the French Federation of Cardiology (FFC) and focuses on the use of cardiovascular magnetic resonance imaging (CMRI) to study atherosclerosis and myocardial viability using different contrast agents. He is an active member of the AHA, the Society for Cardiovascular Magnetic Resonance (SCMR), and the International Society for Magnetic Resonance in Medicine (ISMRM). Over the past three years, Dr Sirol has contributed greatly to the evolving imaging technique known as molecular MRI. He gained his PhD in atherothrombosis and MRI at the Mount Sinai School of Medicine after completing a master’s degree in biological engineering. He also trained in Paris, France.